Biomedical Research Services for Breakthrough Innovations
At HT Biosciences, we partner with global research institutions, biotech firms, and pharmaceutical companies to deliver comprehensive biomedical research services. From target validation to preclinical development, our expertise in advanced models, GLP-compliant protocols, and multidisciplinary platforms accelerates your scientific breakthroughs while ensuring regulatory readiness.
Huateng Biotech delivers end-to-end histology services to support drug development, disease research, and clinical diagnostics. Our ISO 17025-certified labs, FDA-GLP compliance, and cutting-edge digital pathology platforms ensure high-resolution, reproducible results for global academic, pharmaceutical, and clinical partners.
Learn MoreAt Huateng Biotech, we deliver end-to-end in vivo research services designed to meet the highest ethical and scientific standards. Our AAALAC-accredited facilities, FDA-GLP compliance, and decades of expertise ensure robust, reproducible outcomes for drug discovery, disease modeling, and therapeutic validation.
Learn MoreHuateng Biotech provides comprehensive in vitro research services to drive breakthroughs in drug discovery, biotechnology, and disease mechanism studies. Our ISO 17025-certified labs, cutting-edge technologies, and GLP-compliant workflows ensure high-quality, reproducible data for global clients.
Learn MoreGlobal Compliance: AAALAC-accredited facilities with IACUC protocols aligned with EU Directive 2010/63/EU and USDA standards.
Advanced Imaging: DSA, IVUS, angiography, and micro-CT for real-time device performance tracking.
Custom Model Development: Species-specific animal models for complex disease states.
Histopathology Suite: SEM/TEM analysis with GLP-grade reporting for PMDA/CE Mark submissions.